IL117050A0 - Solid active ingredient compositions containing hydroxypropylcellulose - Google Patents

Solid active ingredient compositions containing hydroxypropylcellulose

Info

Publication number
IL117050A0
IL117050A0 IL11705096A IL11705096A IL117050A0 IL 117050 A0 IL117050 A0 IL 117050A0 IL 11705096 A IL11705096 A IL 11705096A IL 11705096 A IL11705096 A IL 11705096A IL 117050 A0 IL117050 A0 IL 117050A0
Authority
IL
Israel
Prior art keywords
active ingredient
compositions containing
solid active
ingredient compositions
containing hydroxypropylcellulose
Prior art date
Application number
IL11705096A
Other languages
English (en)
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of IL117050A0 publication Critical patent/IL117050A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11705096A 1995-02-14 1996-02-06 Solid active ingredient compositions containing hydroxypropylcellulose IL117050A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19504831A DE19504831A1 (de) 1995-02-14 1995-02-14 Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose

Publications (1)

Publication Number Publication Date
IL117050A0 true IL117050A0 (en) 1996-06-18

Family

ID=7753889

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11705096A IL117050A0 (en) 1995-02-14 1996-02-06 Solid active ingredient compositions containing hydroxypropylcellulose

Country Status (9)

Country Link
EP (1) EP0809487A1 (ja)
JP (1) JPH11501618A (ja)
CN (1) CN1174502A (ja)
AU (1) AU4717096A (ja)
CA (1) CA2211671A1 (ja)
DE (1) DE19504831A1 (ja)
IL (1) IL117050A0 (ja)
WO (1) WO1996025149A1 (ja)
ZA (1) ZA961138B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19536387A1 (de) * 1995-09-29 1997-04-03 Basf Ag Verfahren zur Herstellung von vitaminhaltigen festen Zubereitungen
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
IT1298574B1 (it) * 1998-02-06 2000-01-12 Vectorpharma Int Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
DE19842753A1 (de) 1998-09-18 2000-03-23 Bayer Ag Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
DE19934610A1 (de) * 1999-07-23 2001-01-25 Bayer Ag Schnellfreisetzende Extrudate und Verfahren zu ihrer Herstellung sowie daraus erhältliche Zubereitungen
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
JP4310605B2 (ja) * 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
TW200526274A (en) 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
JP5400377B2 (ja) * 2005-05-10 2014-01-29 ノバルティス アーゲー 圧縮性に乏しい治療用化合物を有する組成物の製造法
CN100448432C (zh) * 2006-10-26 2009-01-07 徐竹青 高溶出度尼莫地平分散片的制备方法
JP2011503048A (ja) 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
CA2830765C (en) 2011-03-21 2019-02-05 Boehringer Ingelheim International Gmbh Solid preparation containing ambroxol
WO2018219801A1 (en) 2017-06-02 2018-12-06 Bayer Pharma Aktiengesellschaft Immediate-release extrudates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769029A (en) * 1971-05-26 1973-10-30 Hercules Inc Method of making a thermoplastic food product
US4014675A (en) * 1974-12-05 1977-03-29 Hercules Incorporated Fertilizer stick
JPS5879915A (ja) * 1981-11-09 1983-05-13 Nippon Soda Co Ltd 棒状薬剤の製造方法
JPS58192817A (ja) * 1982-05-06 1983-11-10 Nippon Soda Co Ltd 棒状製剤の製造方法
JPH03145418A (ja) * 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
DE4226753A1 (de) * 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery

Also Published As

Publication number Publication date
AU4717096A (en) 1996-09-04
WO1996025149A1 (de) 1996-08-22
ZA961138B (en) 1997-08-13
EP0809487A1 (de) 1997-12-03
DE19504831A1 (de) 1996-09-05
JPH11501618A (ja) 1999-02-09
CA2211671A1 (en) 1996-08-22
CN1174502A (zh) 1998-02-25

Similar Documents

Publication Publication Date Title
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
IL116455A0 (en) Imidazole compounds and pharmaceutical compositions containing them
EG23826A (en) Pharmaceutical formulations
GB9523752D0 (en) Pharmaceutical formulations
EP0727217A3 (en) Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
IL122618A0 (en) Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
HU9802795D0 (en) Pharmaceutical compositions containing more active components
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
ZA967827B (en) Pharmaceutical compositions
EG24294A (en) Pharmaceutical compositions
IL117943A (en) Dihalopropene compounds and insecticides containing them as active ingredients
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
GB9523566D0 (en) Pharmaceutical formulation
IL126050A0 (en) Sustained-release pharmaceutical formulations containing mizolastin
ZA96526B (en) Novel pharmaceutical formulation
AU1172097A (en) Pharmaceutical composition containing trehalose
PL323592A1 (en) Fungicidal combinations of active substances
EP0742281A3 (en) Fluorescent-whitening agents containing formulations
ZA96392B (en) Pharmaceutical formulations
HUP9901162A3 (en) Compounds and compositions for delivering active agents